For horses that respond to OSPHOS and manage their medical advancement for 6 months, you'll want to re-administer only when clinical symptoms recur. This quite early reaction is probably not a sign of the lengthy-term usefulness in the medication (it might be impartial of the principle, bone modifying outcomes). In the situation of navicular syn